• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK ® XS SYSTEM; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Catalog Number 04625374160
Device Problem High Test Results (2457)
Patient Problems Visual Impairment (2138); Dizziness (2194); Balance Problems (4401); Speech Disorder (4415); Ischemia Stroke (4418)
Event Date 08/28/2021
Event Type  Injury  
Manufacturer Narrative
The meter was provided for investigation.Upon investigation, the returned meter failed to power on with fresh retention batteries.Examination of the battery compartment revealed heavy contamination due to a leaked battery.The contamination prevents the meter from powering on.The meter cannot be tested further.The test strips were provided for investigation where they were tested using a retention meter and retention controls.Testing results (qc range = 4.1 - 6.8 inr): qc 1: 5.2 inr, qc 2: 5.0 inr, qc 3: 5.2 inr.The obtained qc values were in the allowed range of the used combination strip lot - qc lot.All measurements were without error messages.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Occupation was patient/consumer.The initial reporter was the patient's husband.
 
Event Description
There was an allegation of questionable results from coaguchek xs meter serial number (b)(4) and an allegation the patient had a cerebral stroke due to blood clots generated by a st jude valve because the patient's inr was low.On (b)(6) 2021, the patient had double vision and felt dizzy so she was driven to the hospital.Testing on the meter was not performed prior to going to the hospital on this date.The result from the hospital laboratory using an unknown reagent was reportedly 1.0 inr.The patient was reportedly put on lovenox based on this result.A ct (computed tomography) scan was performed which reportedly showed a hemorrhage in the brain, but allegedly no bleeding was found in the brain.When asked about the ct scan findings, the reporter alleged that the doctor suspects that it was a hemorrhage but no blood was detected on the ct scan.On (b)(6) 2021, the patient had an mri and an mra that reportedly showed there were a few small clots located in the narrow lower part of the brain stem.No blood loss was seen.An ultrasound of the heart was performed and the valve evaluation was okay.The patient was hospitalized for a week and because of the stroke, the patient has double vision, tremors in the hand, balance issues, and some speech issues.The patient is reportedly continuing to improve in all areas of recovery.The therapeutic range was 2.5-3.5 inr and the patient tests weekly.This mdr is being submitted in an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK ® XS SYSTEM
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12869155
MDR Text Key281213019
Report Number1823260-2021-03473
Device Sequence Number1
Product Code GJS
UDI-Device Identifier00365702127104
UDI-Public00365702127104
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 11/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/24/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date07/31/2022
Device Catalogue Number04625374160
Device Lot Number52333121
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/09/2021
Date Manufacturer Received10/29/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ATORVASTATIN; CENTRUM VITAMIN COMPLEX; DULOXETINE; HUMALOG; METOPROLOL; NIFEDIPINE; RAMIPRIL; TOLTERODINE; TRULICITY; WARFARIN
Patient Outcome(s) Hospitalization; Other;
Patient Age77 YR
Patient SexFemale
Patient Weight102 KG
-
-